Company Filing History:
Years Active: 2008
Title: Valeria Ugo: Innovator in Genetic Diagnostics
Introduction
Valeria Ugo is a prominent inventor based in Paris, France. She has made significant contributions to the field of genetic diagnostics, particularly in relation to myeloproliferative disorders. Her work has implications for the diagnosis and treatment of various blood-related conditions.
Latest Patents
Valeria Ugo holds a patent for the identification of a JAK2 mutation in Polycythemia Vera. This invention concerns the V617F variant of the protein-tyrosine kinase JAK2, which is responsible for Vaquez Polyglobulia. The patent also describes a first intention diagnostic method for erythrocytosis and thrombocytosis, allowing their association with myeloproliferative disorders. Additionally, it facilitates the detection of the JAK2 V617F variant in these disorders, enabling their reclassification into a new nosological group. She has 1 patent to her name.
Career Highlights
Valeria Ugo is currently associated with Ipsogen, a company known for its focus on molecular diagnostics. Her work at Ipsogen has been instrumental in advancing the understanding of genetic mutations and their implications for patient care.
Collaborations
Throughout her career, Valeria has collaborated with notable professionals in her field, including William Vainchenker and James Chloe. These collaborations have enriched her research and contributed to the development of innovative diagnostic methods.
Conclusion
Valeria Ugo's contributions to genetic diagnostics, particularly through her patent on the JAK2 mutation, highlight her role as a leading inventor in the medical field. Her work continues to impact the diagnosis and treatment of myeloproliferative disorders, showcasing the importance of innovation in healthcare.